Cargando…
Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells
Deregulated WNT/β-catenin signaling contributes to the development of a subgroup of hepatocellular carcinoma (HCC), the second leading cause of cancer deaths worldwide. Within this pathway, the tankyrase enzymes (TNKS1 and TNKS2) degrade AXIN and thereby enhance β-catenin activity. We evaluate TNKS...
Autores principales: | Ma, Li, Wang, Xiaolin, Jia, Tao, Wei, Wei, Chua, Mei-Sze, So, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694839/ https://www.ncbi.nlm.nih.gov/pubmed/26246473 |
Ejemplares similares
-
WIKI4, a Novel Inhibitor of Tankyrase and Wnt/ß-Catenin Signaling
por: James, Richard G., et al.
Publicado: (2012) -
NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation
por: Lu, Wen-Jing, et al.
Publicado: (2015) -
Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling
por: Mariotti, Laura, et al.
Publicado: (2016) -
Discovery of Novel Inhibitor for WNT/β-Catenin Pathway by Tankyrase 1/2 Structure-Based Virtual Screening
por: Li, Bo, et al.
Publicado: (2020) -
Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta
por: Martino-Echarri, Estefania, et al.
Publicado: (2016)